Page last updated: 2024-10-25

debrisoquin and Acute Hepatic Failure

debrisoquin has been researched along with Acute Hepatic Failure in 2 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, RR1
Zheng, YW1
Li, B1
Tsuchida, T1
Ueno, Y1
Nie, YZ1
Taniguchi, H1
Gustafsson, LL1
Eriksson, LS1
Dahl, ML1
Eleborg, L1
Ericzon, BG1
Nyberg, A1

Other Studies

2 other studies available for debrisoquin and Acute Hepatic Failure

ArticleYear
Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities.
    Stem cell research & therapy, 2015, Mar-26, Volume: 6

    Topics: Animals; Cell Differentiation; Cell Proliferation; Cells, Cultured; Chimera; Debrisoquin; Diphtheria

2015
Cyclophosphamide-induced acute liver failure requiring transplantation in a patient with genetically deficient debrisoquine metabolism: a causal relationship?
    Journal of internal medicine, 1996, Volume: 240, Issue:5

    Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cytochrome P-450 CYP2D6; Debrisoquin;

1996